Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract

NCT04695951 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT04695951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04695951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract
Lead sponsor
Catalysis SL
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2019
Completion date
October 1, 2020
Enrollment
155 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney calculi, kidney injury, renal disease, renal injury, renal stone, ureteral calculi, ureteral injury, ureteral obstruction, urolithiasis, urolithiasis, calcium oxalate, urolithiasis; lower urinary tract